Social Media Buzz 4/27/12

Vernalis Vernalis has reached a research milestone as part of the oncology drug discovery alliance with French pharmaceutical company, Servier

CytRx CytRx Initiates Phase 2 Clinical Trial with INNO-206 in Pancreatic Cancer

Cryolife CryoLife Reports Record Quarterly Revenues in First Quarter of 2012

Repligen Repligen hit by FDA setback, shares plummet 41 percent

Click here to subscribe to daily news headlines in your email inbox